Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Cash from Investing Activities (2016 - 2026)

Viking Therapeutics (VKTX) has disclosed Cash from Investing Activities for 12 consecutive years, with $54.2 million as the latest value for Q1 2026.

  • For Q1 2026, Cash from Investing Activities fell 14.32% year-over-year to $54.2 million; the TTM value through Mar 2026 reached $332.3 million, up 1195.76%, while the annual FY2025 figure was $341.4 million, 161.69% up from the prior year.
  • Cash from Investing Activities hit $54.2 million in Q1 2026 for Viking Therapeutics, down from $75.6 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $160.0 million in Q3 2025 and bottomed at -$459.8 million in Q1 2024.
  • Average Cash from Investing Activities over 5 years is -$16.6 million, with a median of $19.0 million recorded in 2022.
  • Year-over-year, Cash from Investing Activities tumbled 21018.65% in 2024 and then soared 1048.42% in 2025.
  • Viking Therapeutics' Cash from Investing Activities stood at $7.3 million in 2022, then surged by 392.19% to $35.7 million in 2023, then crashed by 81.57% to $6.6 million in 2024, then skyrocketed by 1048.42% to $75.6 million in 2025, then fell by 28.33% to $54.2 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $54.2 million, $75.6 million, and $160.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.